New drug cocktail targets Hard-to-Treat breast cancer
NCT ID NCT07405801
First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 4 times
Summary
This phase 2 trial is testing whether adding a drug called inavolisib to two standard treatments (ribociclib and fulvestrant) can shrink tumors or slow cancer growth in people with advanced hormone-receptor-positive, HER2-negative breast cancer that has a specific genetic change (loss of chromosome 8p) but no PIK3CA mutation. About 80 participants will be randomly assigned to receive either the three-drug combo or a placebo plus the two standard drugs. The study is currently recruiting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- inavolisib, ribociclib, and fulvestrant
- What this could lead to
- If successful, this could offer a new targeted treatment option for people with a specific type of advanced breast cancer that has stopped responding to hormone therapy.
- What could go wrong
- This is an early phase 2 trial with only 80 participants, so results may not apply to everyone. The combination may cause side effects or fail to improve outcomes compared to standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AMG Oncology and Hematology Avera Cancer Institute - Yankton
RECRUITINGYankton, South Dakota, 57078, United States
-
Antiguo Hospital Civil de Guadalajara Fray Antonio Alcalde
RECRUITINGGuadalajara, 44280, Mexico
-
Asst Papa Giovanni XXIII
RECRUITINGBergamo, Lombardy, 24127, Italy
-
Avera Cancer Institute
RECRUITINGSioux Falls, South Dakota, 57105, United States
-
Avera Cancer Institute - Aberdeen
RECRUITINGAberdeen, South Dakota, 57401, United States
-
Avera Cancer Institute - Marshall
RECRUITINGMarshall, Minnesota, 56258, United States
-
Avera Cancer Institute - Mitchell
RECRUITINGMitchell, South Dakota, 57301, United States
-
Avera Cancer Institute - Pierre, SD
RECRUITINGPierre, South Dakota, 57501, United States
-
Bialostockie Centrum Onkologii
RECRUITINGBialystok, 15-027, Poland
-
CIUSSS du Saguenay Lac-Saint-Jean, Chicoutimi Hospital
RECRUITINGChicoutimi, Quebec, G7H 5H6, Canada
-
COZL Oddzial Onkologii Klinicznej z pododdzialem Chemioterapii Dziennej
RECRUITINGLublin, 20-090, Poland
-
Centre Leon Berard
RECRUITINGLyon, 69008, France
-
Centre Oscar Lambret
RECRUITINGLille, 59020, France
-
Centro Médico Fleischer
RECRUITINGCapital Federal, C1414, Argentina
-
Centro Oncologico Korben
RECRUITINGCaba, C1426AGE, Argentina
-
Centro de Investigacion Clinica de Oaxaca
RECRUITINGOaxaca City, Oaxaca, 68020, Mexico
-
Christie Hospital Nhs Trust
RECRUITINGManchester, M20 4GJ, United Kingdom
-
Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda
RECRUITINGSão Paulo, São Paulo, 01317-000, Brazil
-
Dolno?l?skie Centrum Onkologii
RECRUITINGWroc?aw, 53-413, Poland
-
Gachon University Gil Medical Center
RECRUITINGNamdong-Gu, 21565, South Korea
-
Hospital Brasilia
RECRUITINGBrasília, Federal District, 71.635-610, Brazil
-
Hospital Clinic Barcelona
RECRUITINGBarcelona, 08036, Spain
-
Hospital Clinico Universitario de Valencia
RECRUITINGValencia, 46010, Spain
-
Hospital Ramon y Cajal
RECRUITINGMadrid, 28034, Spain
-
Hospital Santa Rita de Cassia Vitoria
RECRUITINGVitória, Espírito Santo, 29043-260, Brazil
-
Hospital Universitario 12 de Octubre
RECRUITINGMadrid, 28041, Spain
-
Hospital Universitario Clínico San Cecilio
RECRUITINGGranada, 18016, Spain
-
ICO L'Hospitalet
RECRUITINGL'Hospitalet de Llobregat, Barcelona, 08908, Spain
-
IRST Istituto Scientifico Romagnolo Per Lo Studio E Cura Dei Tumori, Sede Meldola
RECRUITINGMeldola, Emilia-Romagna, 47014, Italy
-
Ictrials Pesquisa e Desenvolvimento
RECRUITINGCuritiba, Paraná, 80510-130, Brazil
-
Inst. Alexander Fleming
RECRUITINGBuenos Aires, C1426ANZ, Argentina
-
Institut Paoli Calmettes
RECRUITINGMarseille, 13273, France
-
Institut Régional du Cancer de Montpellier
RECRUITINGMontpellier, 34298, France
-
Institut Universitaire du Cancer - Oncopole Toulouse (IUCT-O)
RECRUITINGToulouse, 31059, France
-
Instituto Nacional De Cancerologia
RECRUITINGDistrito Federal, Mexico CITY (federal District), 14000, Mexico
-
Instytut "Centrum Zdrowia Matki Polki"
RECRUITING?ód?, 93-338, Poland
-
Irccs Istituto Nazionale Dei Tumori (Int)
RECRUITINGMilan, Lombardy, 20133, Italy
-
Istituto Nazionale Tumori Irccs Fondazione g. PASCALE
RECRUITINGNaples, Campania, 80131, Italy
-
Leicester Royal Infirmary
RECRUITINGLeicester, LE1 5WWi, United Kingdom
-
Los Angeles Cancer Network - Anaheim
RECRUITINGAnaheim, California, 92805, United States
-
McGill University
RECRUITINGMontreal, Quebec, H4A 3J1, Canada
-
Nationales Centrum für Tumorerkrankungen (NCT)
RECRUITINGHeidelberg, 69120, Germany
-
Ospedale San Raffaele
RECRUITINGMilan, Lombardy, 20132, Italy
-
Ottawa General Hospital
RECRUITINGOttawa, Ontario, K1H 8L6, Canada
-
Royal Free Hospital
RECRUITINGLondon, NW3 2QG, United Kingdom
-
Sanatorio de la Mujer
RECRUITINGRosario, S2000ORE, Argentina
-
Seoul National University Bundang Hospital
RECRUITINGSeongnam-si, 13605, South Korea
-
Seoul National University Hospital
RECRUITINGSeoul, 03080, South Korea
-
Soon Chun Hyang University Cheonan Hospital
RECRUITINGDongnam-gu, Cheonan-si, 31151, South Korea
-
Stanford Cancer Institute
RECRUITINGPalo Alto, California, 94304, United States
-
Sunnybrook Health Science Centre
RECRUITINGToronto, Ontario, M4N 3M5, Canada
-
Uniklinik RWTH Aachen Klinik für Gynäkologie und Geburtsmedizin
RECRUITINGAachen, 52074, Germany
-
Università Campus Bio-Medico di Roma
RECRUITINGRome, Lazio, 128, Italy
-
Universitätsklinik Tübingen
RECRUITINGTübingen, 72076, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?